Dabur India Ltd. News and Updates

Name: Latest research reports of Dabur India Ltd. authored by IDBI Capital and published by - Trendlyne research reports.
Item: Dabur India Ltd.
Rating: 4
Author: IDBI Capital

Keep track of all breaking news on Dabur India Ltd. from all sources in a single place.

Load latest

Dabur India Ltd.

04 Nov 2020

545.30

-0.40%

Dabur India: Q2FY21 Result Review

Accumulate: Dabur India Ltd.

IDBI Capital

DABUR India (DABUR) 2QFY21 result was above our estimates. Consolidated revenue growth recovered to high double digit after two consecutive quarter of decline. Health supplement portfolio delivered astronomical 71%YoY revenue growth driven by 2x sales of Chyawanprash. In HPC; oral care, hygiene and shampoo portfolio revenue grew at 18-38% rate while revenue from Odomos, Odonil and Hair Oil portfolio declined 6-10%. Food continues to face growth head-winds due to sub-par performance of beverage portfolio. Performance of international business remained satisfactory. We expect DABUR, as a category leader in India, to benefit from the penetration of...

Number of FII/FPI investors decreased from 764 to 755 in Jun 2025 qtr

Dabur India Ltd.

04 Nov 2020

545.30

-0.40%

Result Update:Dabur India

Buy: Dabur India Ltd.

Axis Direct

We have marginally revised our estimates for FY21/22/23E for double digit volume growth and strategic shift in A&P; spends. Retain BUY with unchanged TP of Rs.610 as we value the stock at 50x its FY23E EPS.

Axis Direct increased Hold price target of Dabur India Ltd. to 630.0 on 05 Sep, 2025.

Dabur India Ltd.

04 Nov 2020

545.30

-0.40%

Dabur India

Buy: Dabur India Ltd.

Target

ICICI Securities Limited

During the quarter, sales of health supplements, OTC, ethical saw 70.8%, 56.1% & 26.4% growth, respectively. Further, oral care & shampoo also witnessed 24.2% & 17.8% growth, respectively. The company continues to strengthen its market share in Chyawanprash (190 bps increase), toothpaste (90 bps increase) and shampoo (80 bps increase). We believe growth in health & immunity products is far more structural compared to hygiene or instant food products. The penetration levels of Chyawanprash & honey is ~4% & ~25%, respectively, which poses immense growth opportunity in...

Dabur India Ltd. is trading above all available SMAs

Dabur India Ltd.

03 Nov 2020

545.30

-0.40%

Immunity-boosting products outperformer for Dabur; sales of sanitiser drops: CEO Malhotra

Moneycontrol

The 136-year-old company will continue its innovation-based journey, going forward as well

Axis Direct increased Hold price target of Dabur India Ltd. to 630.0 on 05 Sep, 2025.

Dabur India Ltd.

03 Nov 2020

545.30

-0.40%

Strong all round performance augurs well for future

Buy: Dabur India Ltd.

Recommendation Target

Motilal Oswal

Dabur reported a significant beat on the topline and volumes (third highest growth in the past 50 quarters). The Healthcare portfolio fared even better in 2QFY21 (49.3% YoY growth) v/s 1QFY21 (27.7% growth). Notably, Dabur surprised in the Home & Personal Care (HPC) and Food & Beverage (F&B;) segments HPC reported 9.1% YoY growth in 2QFY21 (14.1% decline in 1QFY21), and decline in F&B; was restricted to 3.8% YoY (34.2% decline in 1QFY21 and weak numbers for several preceding quarters). While Healthcare may face a higher base from 3QFY21, the performances of the...

Number of FII/FPI investors decreased from 764 to 755 in Jun 2025 qtr

Dabur India Ltd.

06 Oct 2020

545.30

-0.40%

Initiating Coverage:Dabur India

Buy: Dabur India Ltd.

Target

Axis Direct

We value Dabur at 50x FY23E EPS at a discount to its 3 year avg. PE of 53x given its market leadership in Ayurvedic category, rich legacy, fearlessness in NPD launches, healthy margins and operating cash flows. We initiate coverage with a BUY rating and TP of Rs. 610/share.

Dabur India Ltd. has an average target of 563.57 from 7 brokers.

Dabur India Ltd.

02 Oct 2020

545.30

-0.40%

Colors ropes in 15 sponsors for Bigg Boss Hindi

Business Line

MPL is presenting sponsor while Dabur Dant Rakshak and TRESemm are powered by' sponsors

Axis Direct increased Hold price target of Dabur India Ltd. to 630.0 on 05 Sep, 2025.

Dabur India Ltd.

21 Sep 2020

545.30

-0.40%

DABUR INDIA LTD.

Buy: Dabur India Ltd.

Ventura

We initiate coverage on Dabur with a BUY for a price target of Rs.600 representing a potential appreciation of 22 % over the next 24 month from the CMP of Rs.490.